{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T20:36:39Z","timestamp":1790973399059,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Epidemiology"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1016\/j.annepidem.2007.10.006","type":"journal-article","created":{"date-parts":[[2008,3,27]],"date-time":"2008-03-27T10:26:12Z","timestamp":1206613572000},"page":"270-282","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Hierarchical Changepoint Models for Biochemical Markers Illustrated by Tracking Postradiotherapy Prostate-Specific Antigen Series in Men With Prostate Cancer"],"prefix":"10.1016","volume":"18","author":[{"given":"Carine A.","family":"Bellera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Hanley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.","family":"Albertsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.annepidem.2007.10.006_bib1","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2307\/2347570","article-title":"Hierarchical Bayesian analysis of changepoint problems","volume":"41","author":"Carlin","year":"1992","journal-title":"Appl Stat"},{"key":"10.1016\/j.annepidem.2007.10.006_bib2","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2307\/2986119","article-title":"Bayesian retrospective multiple-changepoint identification","volume":"43","author":"Stephens","year":"1994","journal-title":"Appl Stat"},{"key":"10.1016\/j.annepidem.2007.10.006_bib3","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1080\/01621459.1992.10475258","article-title":"Hierarchical Bayes models for the progression of HIV infection using longitudinal CD4 T-cell numbers","volume":"87","author":"Lange","year":"1992","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.annepidem.2007.10.006_bib4","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1002\/sim.2671","article-title":"Random changepoint modelling of HIV immunologic responses","volume":"26","author":"Ghosh","year":"2007","journal-title":"Stat Med"},{"key":"10.1016\/j.annepidem.2007.10.006_bib5","first-page":"395","article-title":"Using PSA to detect prostate cancer onset: an application of Bayesian retrospective and prospective changepoint identification","volume":"volume 4","author":"Slate","year":"1999"},{"key":"10.1016\/j.annepidem.2007.10.006_bib6","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/(SICI)1097-0258(20000229)19:4<617::AID-SIM360>3.0.CO;2-R","article-title":"Statistical models for longitudinal biomarkers of disease onset","volume":"19","author":"Slate","year":"2000","journal-title":"Stat Med"},{"key":"10.1016\/j.annepidem.2007.10.006_bib7","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/biostatistics\/kxh003","article-title":"Combining longitudinal studies of PSA","volume":"5","author":"Inoue","year":"2004","journal-title":"Biostatistics"},{"key":"10.1016\/j.annepidem.2007.10.006_bib8","first-page":"435","article-title":"Changepoint modeling of longitudinal PSA as biomarker for prostate cancer","volume":"volume 3","author":"Slate","year":"1999"},{"key":"10.1016\/j.annepidem.2007.10.006_bib9","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1002\/sim.1392","article-title":"Predicting time to prostate cancer recurrence based on joint models for non-linear longitudinal biomarkers and event time outcome","volume":"21","author":"Pauler","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/j.annepidem.2007.10.006_bib10","doi-asserted-by":"crossref","first-page":"10963","DOI":"10.1093\/oxfordjournals.aje.a009741","article-title":"Taking account of between-patient variability when modeling decline in Alzheimer's disease","volume":"149","author":"Joseph","year":"1999","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.annepidem.2007.10.006_bib11","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1001\/jama.289.20.2695","article-title":"Variation of serum prostate-specific antigen levels","volume":"289","author":"Eastham","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.annepidem.2007.10.006_bib12","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1001\/jama.1992.03480160073037","article-title":"Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease","volume":"267","author":"Ballentine Carter","year":"1992","journal-title":"JAMA"},{"key":"10.1016\/j.annepidem.2007.10.006_bib13","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1097\/01.ju.0000124381.93689.b4","article-title":"Validation of increasing prostate specific antigen as a predictor of prostate cancer death after treatment of localized cancer with surgery or radiation","volume":"171","author":"Albertsen","year":"2004","journal-title":"J. Urol"},{"key":"10.1016\/j.annepidem.2007.10.006_bib14","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1002\/1097-0142(19930315)71:6<2031::AID-CNCR2820710618>3.0.CO;2-Q","article-title":"Observations on the doubling time of prostate cancer. The use of serial prostate-specific antigen in patients with untreated disease as a measure of increasing volume","volume":"71","author":"Schmid","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.annepidem.2007.10.006_bib15","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/0360-3016(90)90504-D","article-title":"A prospective study of prostate specific antigen levels in patients receiving radiotherapy for localized carcinoma of the prostate","volume":"19","author":"Meek","year":"1990","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.annepidem.2007.10.006_bib16","series-title":"Bayesian data analysis","author":"Gelman","year":"2004"},{"key":"10.1016\/j.annepidem.2007.10.006_bib17","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1214\/06-BA117A","article-title":"Prior distributions for variance parameters in hierarchical models","volume":"1","author":"Gelman","year":"2006","journal-title":"Bayesian Anal"},{"key":"10.1016\/j.annepidem.2007.10.006_bib18","series-title":"WinBUGS: Bayesian inference using Gibbs sampling, version 1.3","author":"Spiegelhalter","year":"2000"},{"key":"10.1016\/j.annepidem.2007.10.006_bib19","first-page":"S42","article-title":"Determinants of prostate cancer specific survival following therapy during the prostate specific antigen era","volume":"170","author":"D'Amico","year":"2003","journal-title":"J. Urol"},{"key":"10.1016\/j.annepidem.2007.10.006_bib20","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/1097-0142(19930801)72:3<832::AID-CNCR2820720332>3.0.CO;2-6","article-title":"The fall and rise of prostate-specific antigen: kinetics of serum prostate specific antigen levels after radiation therapy for prostate cancer","volume":"72","author":"Zagars","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.annepidem.2007.10.006_bib21","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/1097-0142(19940715)74:2<670::AID-CNCR2820740220>3.0.CO;2-8","article-title":"Prostate specific antigen doubling time and disease relapse after radiotherapy for prostate cancer","volume":"74","author":"Pollack","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.annepidem.2007.10.006_bib22","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/sim.4780100306","article-title":"A statistical method for assessing a threshold in epidemiological studies","volume":"10","author":"Ulm","year":"1991","journal-title":"Stat Med"},{"key":"10.1016\/j.annepidem.2007.10.006_bib23","first-page":"1035","article-title":"American Society for Therapeutic Radiology and Oncology Consensus Panel. Consensus statement: Guidelines for PSA following radiation therapy","volume":"37","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.annepidem.2007.10.006_bib24","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0360-3016(02)02717-7","article-title":"Posttreatment prostate-specific antigen nadir highly predictive of distant failure and death from prostate cancer","volume":"53","author":"Hanlon","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.annepidem.2007.10.006_bib25","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0090-4295(03)00460-6","article-title":"What does post-radiotherapy PSA nadir tell us about freedom from PSA failure and progression-free survival in patients with low and intermediate-risk localized prostate cancer?","volume":"62","author":"DeWitt","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.annepidem.2007.10.006_bib26","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/S0360-3016(01)02764-X","article-title":"Relationship between prostate volume, prostate-specific antigen nadir, and biochemical control","volume":"52","author":"Kaminski","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.annepidem.2007.10.006_bib27","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0022-5347(01)61631-8","article-title":"Prostate specific antigen nadir achieved by men apparently cured of prostate cancer by radiotherapy","volume":"161","author":"Critz","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.annepidem.2007.10.006_bib28","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/(SICI)1097-0142(19980701)83:1<130::AID-CNCR17>3.0.CO;2-Y","article-title":"Modeling postradiation prostate specific antigen level kinetics","volume":"83","author":"Hanlon","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.annepidem.2007.10.006_bib29","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/pros.10176","article-title":"Using splines to detect changes in PSA doubling times","volume":"54","author":"Guess","year":"2003","journal-title":"Prostate"},{"key":"10.1016\/j.annepidem.2007.10.006_bib30","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/biostatistics\/3.4.547","article-title":"The joint modeling of longitudinal disease progression marker and the failure time process in the presence of cure","volume":"3","author":"Law","year":"2002","journal-title":"Biostatistics"},{"key":"10.1016\/j.annepidem.2007.10.006_bib31","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1200\/JCO.2005.12.156","article-title":"Individualized predictions of disease progression following radiotherapy for prostate cancer","volume":"23","author":"Taylor","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.annepidem.2007.10.006_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/biomet\/57.1.1","article-title":"Inference about the change-point in a sequence of random variables","volume":"57","author":"Hinkley","year":"1970","journal-title":"Biometrika"},{"key":"10.1016\/j.annepidem.2007.10.006_bib33","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/biomet\/56.3.495","article-title":"Inference about the intersection in two-phase regression","volume":"56","author":"Hinkley","year":"1969","journal-title":"Biometrika"},{"key":"10.1016\/j.annepidem.2007.10.006_bib34","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/01621459.1995.10476487","article-title":"Estimating unknown transition times using a piecewise nonlinear mixed-effects model in men with prostate cancer","volume":"90","author":"Morrell","year":"1995","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.annepidem.2007.10.006_bib35","first-page":"587","article-title":"Mixed-effects regression models for studying the natural history of prostate disease","volume":"13","author":"Pearson","year":"1994","journal-title":"J Am Stat Assoc"}],"container-title":["Annals of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047279707004425?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047279707004425?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T02:05:04Z","timestamp":1760925904000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1047279707004425"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["S1047279707004425"],"URL":"https:\/\/doi.org\/10.1016\/j.annepidem.2007.10.006","relation":{},"ISSN":["1047-2797"],"issn-type":[{"value":"1047-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hierarchical Changepoint Models for Biochemical Markers Illustrated by Tracking Postradiotherapy Prostate-Specific Antigen Series in Men With Prostate Cancer","name":"articletitle","label":"Article Title"},{"value":"Annals of Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annepidem.2007.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}